BloodGPT

BloodGPT aims to become the universal AI interpretation layer for lab diagnostics - delivering clear, safe, clinically grounded insights to patients, doctors, and health systems, and becoming the stan

BloodGPT targets labs, clinics, and health systems. Running pilots with ALAB, SmartCare Africa, Assuta, Cannaray, GameDay, and Holland & Barrett, with a 12-month forecasted MRR of ~$2M through scale-outs.

Fragmented data across lab results fro patient and doctors, outdated workflows and reports delivery.

BloodGPT provides an AI interpretation layer for lab test results, delivering structured insights, clinical context, and automated reports for patients, doctors, labs, and health systems through API and workflow integrations.

BloodGPT serves B2B clients—clinics, labs, and health systems—via SaaS and API integrations, with growing B2B2C reach through partner networks. Early paid users include doctors and pilot-stage clinical organizations.